The molecular targets for photoreceptor degenerations and uveitis (intraocular inflammation) are poorly understood. A major barrier to progress has been the lack of any specific molecular cause. This proposal builds on our exciting discovery of calcium-activated CAPN5 (calpain-5) as the cause of Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy (ADNIV). CAPN5 is the first nonsyndromic uveitis gene, and makes possible a highly innovative molecular-genetic approach for mechanism-based therapies for inflammation induced by photoreceptor degeneration. Photoreceptors express CAPN5, and an hCAPN5- R243L gain of function mutation in mice shows all the phenotypes of human ADNIV disease. The retina photoreceptors might be particularly sensitive to mutations in CAPN5, because high intracellular calcium is necessary and sufficient to regulate dark adaptation in photoreceptors. Our long-term goals are to find better and more specific treatments for photoreceptor degeneration. Our objective is to use our new hCAPN5-R243L mice to determine whether blocking CAPN5 activity can inhibit degeneration and uveitis. Our central hypothesis is that a calcium-activated CAPN5 pathway leads to ADNIV retinal degeneration and uveitis, and our transgenic CAPN5 mutant mouse is the best available animal model for testing several new uveitis therapies.
Our specific aims are to (1) Treat photoreceptor degeneration in hCAPN5-R243L mice with a pharmacological CAPN5 inhibitor, (2) Rescue the photoreceptor phenotype in hCAPN5-R243L mice with a novel bipartite shRNA gene silencing vector, and (3) Treat uveitis in hCAPN5-R243L mice using commercially available neutralizing antibodies targeting IL-6 and IL-23. Impact. We expect to establish the hCAPN5-R243L mouse as a valuable animal model for testing novel therapies in ADNIV, which can be translated to patients. Our work should help determine the role of of calcium-activated CAPN5 signaling in ADNIV and other photoreceptor degenerations. Since hCAPN5-R243L disease stages phenocopy other eye diseases with photoreceptor degeneration and components of the CAPN5 pathway are found in other forms of uveitis, our studies could have a broad, positive impact, beyond ADNIV and uveitis patients, where components of the CAPN5 pathway may be therapeutic targets.

Public Health Relevance

ADNIV is an inherited eye disease caused by mutations in CAPN5 that cause photoreceptor degeneration and uveitis. Animal model studies of CAPN5 will help us determine effective therapeutic approaches to treat blinding diseases caused by inflammatory retinal degeneration.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY025225-05
Application #
9467552
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Mckie, George Ann
Project Start
2015-05-01
Project End
2019-04-30
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
5
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Stanford University
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Velez, Gabriel; Tang, Peter H; Cabral, Thiago et al. (2018) Personalized Proteomics for Precision Health: Identifying Biomarkers of Vitreoretinal Disease. Transl Vis Sci Technol 7:12
Liu, Katherine Y; Sengillo, Jesse D; Velez, Gabriel et al. (2018) Missense mutation in SLIT2 associated with congenital myopia, anisometropia, connective tissue abnormalities, and obesity. Orphanet J Rare Dis 13:138
DiCarlo, James E; Mahajan, Vinit B; Tsang, Stephen H (2018) Gene therapy and genome surgery in the retina. J Clin Invest 128:2177-2188
Jauregui, Ruben; Thomas, Amanda L; Liechty, Benjamin et al. (2018) SCAPER-associated nonsyndromic autosomal recessive retinitis pigmentosa. Am J Med Genet A :
Cho, Galaxy Y; Schaefer, Kellie A; Bassuk, Alexander G et al. (2018) CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING. Retina 38:1443-1455
Wu, Wen-Hsuan; Tsai, Yi-Ting; Justus, Sally et al. (2018) CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa: A Brief Methodology. Methods Mol Biol 1715:191-205
Tang, Peter H; Kinnick, Tyson R; Folk, James C et al. (2018) PROGRESSION OF SCOTOPIC SINGLE-FLASH ELECTRORETINOGRAPHY IN THE STAGES OF CAPN5 VITREORETINOPATHY. Retin Cases Brief Rep :
Cabral, Thiago; Lima, Luiz H; Mello, Luiz Guilherme M et al. (2018) Bevacizumab Injection in Patients with Neovascular Age-Related Macular Degeneration Increases Angiogenic Biomarkers. Ophthalmol Retina 2:31-37
Roybal, C Nathaniel; Velez, Gabriel; Toral, Marcus A et al. (2018) Personalized Proteomics in Proliferative Vitreoretinopathy Implicate Hematopoietic Cell Recruitment and mTOR as a Therapeutic Target. Am J Ophthalmol 186:152-163
Wert, Katherine J; Velez, Gabriel; Cross, Madeline R et al. (2018) Extracellular superoxide dismutase (SOD3) regulates oxidative stress at the vitreoretinal interface. Free Radic Biol Med 124:408-419

Showing the most recent 10 out of 30 publications